News | September 12, 2024
Merck launches single-use reactor to accelerate ADC manufacturing
Increases efficiency by 70% compared to stainless steel or glass manufacturing methods
Increases efficiency by 70% compared to stainless steel or glass manufacturing methods
PiaSky advances C5 inhibition through innovative recycling technology, which enables its monthly SC administration
MyClad is a global Phase III study evaluating the efficacy and safety of cladribine capsules for the treatment of generalized Myasthenia Gravis (gMG)
H.coagulans is, unlike other general lactobacillus, characterized by spore formation, giving it resistance to acid and heat
PiaSky advances C5 inhibition through innovative recycling technology, which enables its monthly SC administration
ZenBio is a highly regarded science-focused company specializing in biospecimens and related services with scientific expertise
CN201 is a next generation CD3xCD19 bispecific antibody that augments and diversifies Merck’s pipeline, with potential applications in B-cell malignancies and autoimmune diseases
Performed an autologous bone marrow transplant, using the patient’s own cells to reduce the chances of infection and rejection
Boehringer Ingelheim aims to develop this program as a potential key centerpiece component for its immuno-oncology portfolio
Shilpa Biologicals has developed high concentration adalimumab (100 mg/mL)
Subscribe To Our Newsletter & Stay Updated
